![{[setting('site_name')]}](https://projxnews.com/uploads/setting/16983847711140531930.webp)
Atharva Bio Pharma Private Limited is embarking on a significant venture with its Active Pharmaceutical Ingredients (API) Unit Project in Supa, Ahmadnagar, Maharashtra. Valued at a substantial 49 crores, this project marks a considerable investment in the pharmaceutical sector. With an anticipated production capacity of 186.2 tons per month, the facility aims to contribute significantly to the pharmaceutical supply chain, catering to the demand for high-quality APIs.
The project underscores a commitment to meeting the growing need for pharmaceutical ingredients, essential for the formulation of various medicines. Through cutting-edge technology and stringent quality control measures, Atharva Bio Pharma Private Limited endeavors to ensure the production of APIs that meet international standards, thereby fostering trust and reliability among its stakeholders.
One of the key aspects of the project is its focus on environmental sustainability. With a daily capacity to treat 51.1 cubic meters of effluents, the facility aims to minimize its ecological footprint. By implementing advanced wastewater treatment systems, the company demonstrates its responsibility towards environmental conservation, aligning its operations with global sustainability goals.
The API Unit Project holds promise not only in terms of production capacity but also in generating employment opportunities in the region. As a significant industrial initiative in Ahmadnagar, Maharashtra, it is poised to stimulate economic growth and development, contributing to the socio-economic fabric of the local community.
News by Rahul Yelligetti
